

NCT03196843 comparison:

Summary:
CHIA has 13 criteria while your personal folder has 13 criteria
Total found criteria: 13/13
Total not Found: 0/13
Total Extra: 1
This trial is VALID



╒════════════════════════════════════════════════════╤════════════════════════════════════════════════════╕
│ CHIA Criteria                                      │ Matching Personal Criteria                         │
╞════════════════════════════════════════════════════╪════════════════════════════════════════════════════╡
│ Before participate in the study, patients must     │ Before participate in the study, patients must     │
│ understand the treatment plan and willing to       │ understand the treatment plan and willing to       │
│ participate in the study. Patients must have       │ participate in the study. Patients must have       │
│ signed an approved informed consent                │ signed an approved informed consent                │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Histopathologic confirmed squamous cell carcinoma  │ Histopathologic confirmed squamous cell carcinoma  │
│ of head and neck ,including oral cavity,           │ of head and neck ,including oral cavity,           │
│ oropharynx, larynx, or hypopharynx                 │ oropharynx, larynx, or hypopharynx                 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Ages=65 years,Not limited to gender                │ Ages≥65 years,Not limited to gender                │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ ECOG performance status =2                         │ ECOG performance status ≤2                         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patients with surgical contraindication or reject  │ Patients with surgical contraindication or reject  │
│ to surgery                                         │ to surgery                                         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Postoperative TNM(primary tumor,regional           │ Postoperative TNM(primary tumor,regional           │
│ nodes,metastasis) staging III~IV, positive         │ nodes,metastasis) staging III\~IV, positive        │
│ surgical margin                                    │ surgical margin                                    │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ without evidence of distant metastases             │ without evidence of distant metastases             │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ No contraindication to chemoradiotherapy           │ No contraindication to chemoradiotherapy           │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Life expectancy > 3 months                         │ Life expectancy \> 3 months                        │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Available Organ function: white blood              │ Available Organ function: white blood              │
│ cell=3.5×109/L, Neutrophils =1.5×109/L, Hemoglobin │ cell≥3.5×109/L, Neutrophils ≥1.5×109/L, Hemoglobin │
│ =80g/L, Blood platelet>100×109/L; Alanine          │ ≥80g/L, Blood platelet\>100×109/L; Alanine         │
│ aminotransferase (ALT) and Aspartate               │ aminotransferase (ALT) and Aspartate               │
│ aminotransferase (AST)= 2.5 upper limit of         │ aminotransferase (AST)≤ 2.5 upper limit of         │
│ normal(ULN); Total bilirubin (TBIL) <1.5 ULN;serum │ normal(ULN); Total bilirubin (TBIL) \<1.5          │
│ creatinine=1.5 ULN; creatinine clearance of =      │ ULN;serum creatinine≤1.5 ULN; creatinine clearance │
│ 50ml/min                                           │ of ≥ 50ml/min                                      │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patients with a history of any other malignancy    │ Patients with a history of any other malignancy    │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Concomitant treatment with any other anticancer    │ Concomitant treatment with any other anticancer    │
│ therapy                                            │ therapy                                            │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patient have contraindication to                   │ Patient have contraindication to                   │
│ chemotherapy(eg.uncontrolled coronarism and heart  │ chemotherapy(eg.uncontrolled coronarism and heart  │
│ failure; History of myocardial infarction within   │ failure; History of myocardial infarction within   │
│ the past 6 months, Chronic obstructive pulmonary,  │ the past 6 months, Chronic obstructive pulmonary,  │
│ uncontrolled epileptic attack and other disease    │ uncontrolled epileptic attack and other disease    │
│ that investigator consider it unsuitable for the   │ that investigator consider it unsuitable for the   │
│ chemotherapy)                                      │ chemotherapy)                                      │
╘════════════════════════════════════════════════════╧════════════════════════════════════════════════════╛



Everything was Found



╒═══════════════════════════════════╕
│ Extra Personal Criteria           │
╞═══════════════════════════════════╡
│ Must have minimum age of 65 Years │
╘═══════════════════════════════════╛